(a)  

Time, h	RB	RBCUR	RBHYD	RBAA	RBARG	RBLA	RBKA	MUL	CTRL
(i) The percentage of wound closure of NIH 3T3 cell treated with 10% RB maltodextrin (DE 10–14) with 50 ppm of various additives
0					0.00 ± 0.00a A
3	5.69 ± 3.05a A	9.23 ± 0.00b AB	6.43 ± 1.84a A	6.16 ± 3.37a A	8.64 ± 3.92ab AB	5.81 ± 3.80ab A	4.82 ± 4.43a A	0.00 ± 0.00a A	12.04 ± 0.53b D
6	15.72 ± 5.95b A	15.38 ± 0.00b A	18.21 ± 8.87ab A	13.43 ± 4.89b A	18.06 ± 5.25bc A	15.48 ± 3.92b A	10.66 ± 5.63ab A		21.17 ± 1.72b BC
9	23.85 ± 3.20b A	20.00 ± 0.00d A	28.21 ± 9.27bc A	20.34 ± 0.60b A	24.61 ± 3.51cd A	19.35 ± 6.64c A	23.35 ± 9.56bc A		29.93 ± 4.63d DE
12	40.38 ± 4.81c B	26.92 ± 0.00c AB	35.36 ± 12.31cd B	28.92 ± 0.87c A	30.63 ± 2.85d AB	32.90 ± 4.06c AB	31.98 ± 7.20cd AB		36.86 ± 1.47c B
24	100.00 ± 0.00d C	50.77 ± 0.00d B	50.36 ± 2.86d B	47.76 ± 3.33d B	46.86 ± 7.78e B	42.90 ± 0.54d A	41.12 ± 6.36d AB		100.00 ± 0.00d A
(ii) The percentage of wound closure of NIH 3T3 cell treated with 10% RB maltodextrin (DE 10–14) with 100 ppm of various additives
0					0.00 ± 0.00a A
3	19.23 ± 1.65b C	15.79 ± 0.00a B	16.40 ± 0.17b C	14.81 ± 1.44b BC	16.33 ± 1.79b E	17.74 ± 0.00b C	12.10 ± 0.62b A	0.00 ± 0.00a A
6	32.69 ± 0.70b A	29.82 ± 2.11b BC	28.95 ± 4.96c BC	23.33 ± 6.06c BC	31.78 ± 0.92c C	28.09 ± 0.75c AB	21.66 ± 0.00c A
9	48.73 ± 2.32c BC	42.11 ± 6.88b CD	36.36 ± 4.73d DE	30.23 ± 1.52c CD	38.32 ± 0.78d E	34.83 ± 0.00c AB	29.26 ± 0.31d A
12	61.13 ± 1.39d D	52.97 ± 3.68c D	51.52 ± 2.72e C	47.78 ± 1.90d C	47.66 ± 0.75d C	44.94 ± 4.49d B	32.98 ± 0.56e A
24	100.00 ± 0.00e A	100.00 ± 0.00d A	100.00 ± 0.00f A	100.00 ± 0.00e A	100.00 ± 0.00e A	100.00 ± 0.00e A	100.00 ± 0.00f A